Back to discover
Drug

Cocaine

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as Benzoylmethylecgonine, Goprelto, Kokain, L-Cocain+11 more

Benzoylmethylecgonine, Goprelto, Kokain, L-Cocain, L-Cocaine, Methyl benzoylecgonine, Neurocaine, Numbrino, beta-Cocain, cocaine (Schedule I substance), (-)-Cocaine, Cocain, Cocaina, Cocaine Hydrochloride, Cocainum.

6
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study With Pentoxifylline

Clinical trial2026-06-08Results expected Q1 2028 · ClinicalTrials.gov

Behavioral Effects of Drugs (Inpatient): 42 (Cocaine and Zolmitriptan)

Clinical trial2025-08-05Results posted · ClinicalTrials.gov

Intranasal Cocaine and Temperature Regulation During Exercise

Clinical trial2025-07-14Results posted · ClinicalTrials.gov

Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics.

Research2024-12-17Annual review of pharmacology and toxicology

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Cocaine
Aliases & brands
BenzoylmethylecgonineGopreltoKokainL-CocainL-CocaineMethyl benzoylecgonineNeurocaineNumbrinobeta-Cocaincocaine (Schedule I substance)(-)-CocaineCocainCocainaCocaine HydrochlorideCocainum
RxNorm CUI
2653
ChEMBL ID
CHEMBL370805
ATC codes
N01BC01S02DA02S01HA01R02AD03
UNII
I5Y540LHVR

Clinical trials

37 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
37
registered trials across all phases
LATEST COMPLETION 2025
1
Active studies
1
Recruiting
4
Late-stage (III+)
30
Completed
6
Discontinued
PHASE DISTRIBUTIONn = 37
Early Phase 19Phase 118Phase 1 / 23Phase 23Phase 42Phase N / A2

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

6 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20032025
Most influential
Recent papers
Major research themes8
Neuronal Plasticity4Astrocytes2Cocaine2Action Potentials1Adaptation, Psychological1Basic Helix-Loop-Helix Proteins1Central Nervous System Stimulants1Drug-Seeking Behavior1
Journals, researchers & institutions
Top journals
  • The Journal of neuroscience : the official journal of the Society for Neuroscience2
  • Annual review of pharmacology and toxicology1
  • Biological psychiatry1
  • Glia1
  • Science (New York, N.Y.)1
Leading researchers
  • Akiki RM1
  • Alberquilla S1
  • Anesio A1
  • Araque A1
  • Berto S1
  • Betancur C1
  • Bezerra F1
  • Bianchi PC1
Leading institutions
free-text, unnormalised
  • Medical University of South Carolina3
  • Cajal Institute1
  • Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional1
  • Instituto de Salud Carlos III1
  • Kyoto Prefectural University of Medicine1
  • Michigan State University1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Cocaine in the shared literature.

3 shared diseases1 shared paper

Studied across the same disease area as Cocaine in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials